Case Studies
01.01.2023
Development and delivery of advanced value

To deepen our clients understanding and share learning from case studies on advanced access strategy...

Read more
Case Studies
01.01.2023
Enhancing market access capabilities

Development and delivery of a comprehensive pricing, health economics and market access training pro...

Read more
Case Studies
01.01.2023
Developing real-world evidence (RWE) capabilities

Development and delivery of training covering the fundamental principles of RWE, including defining ...

Read more
Case Studies
01.01.2023
Supporting your market access training needs

We offer comprehensive bespoke market access training solutions, which are tailored to the individua...

Read more
Case Studies
01.01.2023
Developing a tender strategy for a rare disease

The company found themselves facing competitive tenders for the first time in this disease space - t...

Read more
Case Studies
01.01.2023
Securing reimbursement for an orphan drug via NICE

Our client was seeking NICE approval for their ultra-orphan drug in an indication that was not well ...

Read more
Case Studies
01.01.2023
Developing scenario-based commercial assessments

Identification of current cost of oncology care treatment options.

Read more
Case Studies
01.01.2023
Development of EU country level biosimilar pricing

Development of local market access plans that could be used by EU affiliates, who had not previously...

Read more
Case Studies
01.01.2023
Development of an EU P&R strategy

Our client needed to understand the clinical and economic evidence requirements that drive payer dec...

Read more
Case Studies
01.01.2023
The impact of international reference pricing

Our client was seeking market authorisation for one indication and were expected a secondary indicat...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.